nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—periodontitis	0.948	1	CbGaD
Drospirenone—PTGS2—periosteum—periodontitis	0.00596	0.202	CbGeAlD
Drospirenone—NR3C2—trigeminal ganglion—periodontitis	0.0027	0.0914	CbGeAlD
Drospirenone—NR3C2—parotid gland—periodontitis	0.00254	0.0862	CbGeAlD
Drospirenone—NR3C2—connective tissue—periodontitis	0.00224	0.0758	CbGeAlD
Drospirenone—PTGS2—endothelium—periodontitis	0.0022	0.0744	CbGeAlD
Drospirenone—PGR—connective tissue—periodontitis	0.00208	0.0705	CbGeAlD
Drospirenone—PGR—epithelium—periodontitis	0.00197	0.0669	CbGeAlD
Drospirenone—PTGS2—mouth—periodontitis	0.00169	0.0574	CbGeAlD
Drospirenone—AR—connective tissue—periodontitis	0.00166	0.0562	CbGeAlD
Drospirenone—BCHE—trigeminal ganglion—periodontitis	0.00162	0.055	CbGeAlD
Drospirenone—AR—epithelium—periodontitis	0.00157	0.0533	CbGeAlD
Drospirenone—PTGS2—trigeminal ganglion—periodontitis	0.00125	0.0424	CbGeAlD
Drospirenone—PGR—Cellular roles of Anthrax toxin—VCAM1—periodontitis	0.00113	0.0515	CbGpPWpGaD
Drospirenone—PTGS2—connective tissue—periodontitis	0.00104	0.0352	CbGeAlD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL18—periodontitis	0.001	0.0456	CbGpPWpGaD
Drospirenone—PTGS2—epithelium—periodontitis	0.000986	0.0334	CbGeAlD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—VDR—periodontitis	0.000858	0.0391	CbGpPWpGaD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—periodontitis	0.00082	0.0373	CbGpPWpGaD
Drospirenone—PGR—Ovarian Infertility Genes—VDR—periodontitis	0.000759	0.0346	CbGpPWpGaD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000724	0.033	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—VDR—periodontitis	0.000662	0.0301	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—PPARA—periodontitis	0.000558	0.0254	CbGpPWpGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.000537	0.0245	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.000523	0.0238	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL1B—periodontitis	0.000523	0.0238	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—VDR—periodontitis	0.000504	0.023	CbGpPWpGaD
Drospirenone—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	0.000493	0.0225	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	0.000479	0.0218	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000441	0.0201	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—PPARA—periodontitis	0.000425	0.0194	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	0.000413	0.0188	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.000398	0.0181	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—periodontitis	0.000379	0.0173	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	0.00034	0.0155	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.000336	0.0153	CbGpPWpGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.000317	0.0144	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—periodontitis	0.000275	0.0125	CbGpPWpGaD
Drospirenone—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	0.000274	0.0125	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	0.000268	0.0122	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—periodontitis	0.000268	0.0122	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL13—periodontitis	0.000253	0.0115	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MPO—periodontitis	0.000239	0.0109	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000231	0.0105	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	0.00023	0.0105	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.000221	0.0101	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	0.00022	0.01	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	0.000206	0.00937	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	0.000187	0.00851	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	0.000184	0.00839	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—periodontitis	0.000178	0.0081	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	0.000174	0.00794	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCR2—periodontitis	0.00016	0.00728	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1A—periodontitis	0.000159	0.00726	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—periodontitis	0.000158	0.00721	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000154	0.00702	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	0.000151	0.00686	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—VDR—periodontitis	0.000148	0.00675	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—periodontitis	0.000148	0.00673	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.000138	0.0063	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—periodontitis	0.000134	0.00609	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	0.000133	0.00606	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—FGF2—periodontitis	0.000133	0.00604	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARA—periodontitis	0.000125	0.00569	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	0.000124	0.00564	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	0.000121	0.00551	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1A—periodontitis	0.000115	0.00522	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL4—periodontitis	0.000111	0.00504	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	9.96e-05	0.00453	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	9.21e-05	0.00419	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—periodontitis	9.18e-05	0.00418	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—VDR—periodontitis	9.03e-05	0.00411	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	8.86e-05	0.00404	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—NOS2—periodontitis	8.73e-05	0.00398	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CXCL8—periodontitis	8.66e-05	0.00394	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	8.61e-05	0.00392	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	8.47e-05	0.00386	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	8.42e-05	0.00383	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1B—periodontitis	8.31e-05	0.00378	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCL2—periodontitis	7.88e-05	0.00359	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC52A3—periodontitis	7.73e-05	0.00352	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL3—periodontitis	7.7e-05	0.00351	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARA—periodontitis	7.62e-05	0.00347	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	7.6e-05	0.00346	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	7.55e-05	0.00344	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—VDR—periodontitis	7.14e-05	0.00325	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—VDR—periodontitis	6.88e-05	0.00313	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IFNG—periodontitis	6.7e-05	0.00305	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—periodontitis	6.52e-05	0.00297	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC52A3—periodontitis	6.36e-05	0.00289	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	6.23e-05	0.00284	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—periodontitis	6.03e-05	0.00275	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARA—periodontitis	6.02e-05	0.00274	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—periodontitis	5.97e-05	0.00272	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARA—periodontitis	5.8e-05	0.00264	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—GGT1—periodontitis	5.69e-05	0.00259	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—periodontitis	5.63e-05	0.00256	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VIP—periodontitis	5.57e-05	0.00254	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.49e-05	0.0025	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	5.48e-05	0.0025	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC52A3—periodontitis	5.32e-05	0.00242	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.13e-05	0.00234	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR2—periodontitis	4.96e-05	0.00226	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—periodontitis	4.87e-05	0.00222	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	4.84e-05	0.0022	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	4.64e-05	0.00211	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ACP5—periodontitis	4.56e-05	0.00208	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	4.42e-05	0.00201	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—periodontitis	4.35e-05	0.00198	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—periodontitis	4.33e-05	0.00197	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LTF—periodontitis	4.32e-05	0.00197	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.08e-05	0.00186	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.92e-05	0.00178	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR2—periodontitis	3.86e-05	0.00176	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB1—periodontitis	3.84e-05	0.00175	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ACP5—periodontitis	3.75e-05	0.00171	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARA—periodontitis	3.67e-05	0.00167	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—periodontitis	3.5e-05	0.00159	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP1—periodontitis	3.45e-05	0.00157	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—periodontitis	3.31e-05	0.00151	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.16e-05	0.00144	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NTRK1—periodontitis	3.15e-05	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ACP5—periodontitis	3.14e-05	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	2.95e-05	0.00134	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP3—periodontitis	2.92e-05	0.00133	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—periodontitis	2.81e-05	0.00128	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.8e-05	0.00128	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARA—periodontitis	2.79e-05	0.00127	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—periodontitis	2.67e-05	0.00122	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.65e-05	0.00121	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GGT1—periodontitis	2.54e-05	0.00115	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—periodontitis	2.22e-05	0.00101	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—periodontitis	1.9e-05	0.000866	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARA—periodontitis	1.81e-05	0.000826	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GGT1—periodontitis	1.75e-05	0.000795	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—periodontitis	1.72e-05	0.000783	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—periodontitis	1.5e-05	0.000685	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—periodontitis	1.36e-05	0.000619	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—periodontitis	1.32e-05	0.000601	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARA—periodontitis	1.25e-05	0.000569	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—periodontitis	1.18e-05	0.000537	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—periodontitis	1.12e-05	0.00051	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—periodontitis	1.08e-05	0.00049	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—periodontitis	8.45e-06	0.000385	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—periodontitis	7.01e-06	0.000319	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—periodontitis	5.28e-06	0.000241	CbGpPWpGaD
